Rotavirus is the most common cause of severe diarrhoea worldwide, affecting over 125 million young children every year in developing countries. The present study is a part of ongoing childhood diarrhoeal surveillance to determine the strain diversity of rotaviruses prevalent in Andaman and Nicobar Islands. From October 2010 to February 2012, 296 stool samples from children (age group 6–60 months) with gastroenteritis were obtained from different referral hospitals/primary health centres and community health centres in Andaman and Nicobar Islands. A total of 47 samples were found positive for GARV. Among these, 21 (44.7%) samples belong to G2P[4], 12 (25.5%) samples were G1P[8], 10 (21.2%) samples belong to G9P[4], 2 (4.3%) samples belong to G1P[4] and 2 (4.3%) samples had a mixed genotype. Rotavirus G2 genotype remains the most common genotype in these islands. The prevalence of G9 rotavirus reported in the present study is higher than that reported from mainland India. The results emphasize the role of the unusual serotype G9 as an epidemiologically important genotype and the need to include G9 specificity in a rotavirus vaccine.

Keywords:
Diarrhoea, Rotavirus, Genotype, unusual
1.
Samajdar S, Ghosh S, Naik TN, Roy S, Sugunan AP: The post-tsunami outbreak of diarrhoeal diseases in Car Nicobar Island, India, was caused by human group A rotavirus G2 strains. J Infect 2008;57:357–359.
2.
World Health Organization. Estimated rotavirus deaths for children under 5 years of age: 2004, 527,000. WHO, 2004. http://www.who.int/immunization_monitoring/burden/rotavirus_estimates/en/index.h.
3.
Jain V, Das BK, Bhan MK, Glass RI, Gentsch JR: The Indian Strain Surveillance Collaborating Laboratories. Great diversity of group A rotavirus strains and high prevalence of mixed rotavirus infections in India. J Clin Microbiol 2001;39:3524–3529.
4.
Matthijnssens J, Ciarlet M, McDonald SM, Attoui H, Bányai K, Brister JR, Buesa J, Esona MD, Estes MK, Gentsch JR, Iturriza-Gómara M, Johne R, Kirkwood, CD, Martella V, Mertens PP, Nakagomi O, Parreño V, Rahman M, Ruggeri FM, Saif LJ, Santos N, Steyer A, Taniguchi K, Patton JT, Desselberger U, Van Ranst M: Uniformity of rotavirus strain nomenclature proposed by the Rotavirus Classification Working Group (RCWG). Arch Virol 2011;156:1397–1413.
5.
Cunliffe NA, Gondwe JS, Graham SM, Thindwa BDM, Dove W, Broadhead RL, Molyneux ME, Hart CA: Rotavirus strain diversity in Blantyre, Malawi, from 1997 to 1999. J Clin Microbiol 2001;39:836–843.
6.
Koopman M, Brown D: Seasonality and diversity of group A rotaviruses in Europe. Acta Paediatr 1999;426:14–19.
7.
Bishop RF, Masendycz PJ, Bugg H, Carlin JB, Barnes GL: Epidemiological patterns of rotaviruses causing severe gastroenteritis in young children throughout Australia from 1993 to 1996. J Clin Microbiol 2001;39:1085–1091.
8.
Bresee JS, Glass RI, Ivanoff B, Gentsch JR: Current status and future priorities for rotavirus vaccine development, evaluation and implementation in developing countries. Vaccine 1999;17:2207–2222.
9.
Hoshino Y, Kapikian A Z: Rotavirus vaccine development for the prevention of severe diarrhoea in infants and young children. Trends Microbiol 1994;2:242–249.
10.
Iturriza Gómara M, Wong C, Blome S, Desselberger U, Gray J: Molecular characterization of VP6 genes of human rotavirus isolates: correlation of genogroups with subgroups and evidence of independent segregation. J Virol 2002;76:6596–6601.
11.
Gouvea V, Glass RI, Woods P, Taniguchi K, Clark HF, Forrester B: Polymerase chain reaction amplification and typing of rotavirus nucleic acid from stool specimens. J Clin Microbiol 1990;28:276–282.
12.
Tamura K, Dudley J, Nei M, Kumar S: MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 2007;24:1596–1599.
13.
Brown DW, Minnie G, Mathan M, Mathew M, Martin R, Beards GM, Mathan VI: Rotavirus epidemiology in Vellore, South India: group, subgroup, serotype and electropherotype. J Clin Microbiol 1998;26:2410–2414.
14.
Das S, Sen A, Uma G, Varghese V, Chaudhuri S, Bhattacharya SK, Krishnan T, Dutta P, Dutta D, Bhattacharya MK, Mitra U, Kobayashi N, Naik TN: Genomic diversity of group A rotavirus strains infecting humans in Eastern India. J Clin Microbiol 2002;40:146–149.
15.
Samajdar S, Ghosh S, Chawla-Sarkar M, Mitra U, Dutta P, Kobayashi N, Naik TN: Increase in prevalence of human group A rotavirus G9 strains as an important VP7 genotype among children in eastern India. J Clin Microbiol 2008;43:334–339.
16.
Ramachandran M, Vij A, Kumar R, Das BK, Gentsch JR, Bhan MK, Glass RI: Lack of maternal antibodies to P serotypes may predispose neonates to infections with unusual rotavirus strains. Clin Diagn Lab Immunol 1998;5:527–530.
17.
Cunliffe NA, Gondwe JS, Broadhead RL, Molyneux ME, Woods PA, Bresee JS, Glass RI, Gentsch JR, Hart CA: Rotavirus G and P types in children with acute diarrhoea in Blantyre, Malawi, from 1997 to 1998: predominance of novel P[6]G8 strains. J Med Virol 1999;57:308–312.
18.
Martella V, Terio V, Gaudio GD, Gentile M, Fiorente P, Barbuti S, Buonavoglia C: Detection of the emerging rotavirus G9 serotype at high frequency in Italy. J Clin Microbiol 2003;41:3960–3963.
19.
Page N, Esona M, Armah G, Nyangao J, Mwenda J, Sebunya T, Basu G, Pyndiah N, Potgieter N, Geyer A, Steele AD: Emergence and characterization of serotype G9 rotavirus strains from Africa. J Infect Dis 2010;202:S55–S63.
20.
Linhares AC, Verstraeten T, Bosch JW, Clemens R, Breuer T: Rotavirus serotype G9 is associated with more-severe disease in Latin America. Clin Infect Dis 2006;43:312–314.
21.
Gouvea V, De Castro L, Timenetsky MC, Greenberg H, Santos N: Rotavirus serotype G5 associated with diarrhoea in Brazilian children. J Clin Microbiol 1994;32:1408–1409.
22.
Bern C, Unicomb L, Gentsch JR, Banul N, Yunus M, Sack RB, Glass RI: Rotavirus diarrhoea in Bangladeshi children: correlation of disease severity with serotypes. J Clin Microbiol 1992;30:3234–3238.
23.
Santos N, Hoshino Y: Global distribution of rotavirus serotypes/ genotypes and its implication for the development and implementation of an effective rotavirus vaccine. Rev Med Virol 2005;5:29–56.
24.
Vesikari T, Karvonen A, Puustinen L, Zeng SQ, Szakal ED, Delem A, De Vos B: Efficacy of RIX 4414 live attenuated human rotavirus vaccine in Finnish infants. Pediatr Infect Dis J 2004;23:937–943.
25.
Vesikari T, Matson DO, Dennehy P, Van Damme P, Santosham M, Rodriguez Z, Dallas MJ, Heyse JF, Goveia MG, Black SB, Shinefield HR, Christie C DC, Ylitalo S, Itzler RF, Coia ML, Onorato MT, Adeyi BA, Marshall GS, Gothefors L, Campens D, Karvonen A, Wat JP, O’Brien KL, DiNubile MJ, Clark HF, Boslego JW, Offit PA, Heaton PM: Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 2006;354:23–33.
26.
Phan TG, Okitsu S, Maneekarn N, Ushijima H: Genetic heterogeneity, evolution and recombination in emerging G9 rotaviruses. Infect Genet Evol 2007;7:656–663.
© 2012 S. Karger AG, Basel
2012
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.